Open Access

Session 8: Primary and Secondary Prevention in Women - Lipid Lowering Agents, Anti-Diabetic Drugs - Antiplatelet Therapy and Anticoagulation

Event: Cardiovascular Pharmacotherapy in Women 2022
Topic: Pharmacology and Pharmacotherapy
Session type: Symposium
Date: 18 February 2022
Time: 15:20 - 16:20

Session

This content is currently on OPEN ACCESS

Sign in to view the resources

3 presentations in this session

Management of dyslipidaemia.

Speaker: Professor H. Drexel (Feldkirch, AT)
Thumbnail

Diabetes, obesity, uric acid.

Speaker: Professor G. Derumeaux (Creteil, FR)
Thumbnail

Antiplatelet agents and DOACs in primary and secondary prevention.

Thumbnail

2 speakers from this session

Professor Heinz Drexel

Vorarlberg Institute for Vascular Investigation and Treatment, Feldkirch (Austria)
13 presentations
2 followers

Professor Genevieve Anne Derumeaux

Mondor Biomedical Research Institute, Creteil (France)
6 presentations
0 follower

Related content

ESC Premium Access

Management of diabetes mellitus in patients with cardiovascular disease

3 December 2021

This platform is supported by

logo Novo Nordisk